결핵 진단 시장 : 검사 유형, 유형, 최종사용자별 - 세계 예측(2025-2030년)

The Tuberculosis Diagnostics Market was valued at USD 3.01 billion in 2023, expected to reach USD 3.17 billion in 2024, and is projected to grow at a CAGR of 5.48%, to USD 4.38 billion by 2030.

The scope of Tuberculosis (TB) Diagnostics encompasses various tests and procedures aimed at identifying Mycobacterium tuberculosis infection. This includes traditional methods like sputum microscopy, culture tests, and newer molecular diagnostics such as nucleic acid amplification tests (NAATs). The necessity for effective TB diagnostics is underscored by the global burden of tuberculosis, which remains a leading cause of death from an infectious disease. Applications stretch from initial diagnosis and monitoring of treatment response to drug susceptibility testing. End-use sectors include hospitals, diagnostic laboratories, and research institutions, emphasizing both clinical and public health perspectives.

Market insights reveal that technological advancements, rising TB prevalence, and improved healthcare infrastructure are primary growth influencers. Particularly, the rapid switch to molecular diagnostics is spurred by their higher accuracy and faster results compared to conventional methods. Potential opportunities lie in emerging economies where TB prevalence is high but diagnostic facilities remain limited. There, partnerships with government health initiatives could expand market reach. However, high costs associated with advanced diagnostics, varied accuracy across different TB strains, and limited awareness in low-income regions pose significant challenges.

Innovation areas ripe for exploration include the development of cost-effective, point-of-care diagnostic tools that offer rapid and reliable results. These could revolutionize TB diagnostics, especially in rural and resource-constrained settings. Moreover, research into drug-resistant TB detection methods could provide essential breakthroughs in combating multi-drug resistant tuberculosis.

As the market predominantly displays a fragmented nature due to numerous local and international players, businesses can succeed by investing in product differentiation and strategic collaborations. Collaboration with NGOs and public health programs can enhance market penetration and outreach efforts. Identifying these drivers and addressing the limitations through targeted research and strategic planning can lead to sustained growth in the tuberculosis diagnostics market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tuberculosis Diagnostics Market

The Tuberculosis Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing burden of tuberculosis globally and need to diagnose at very early stage
  • Increasing R&D investments and intensive diagnostics products in pipelines
  • Supportive government initiatives and rising awareness in the emerging markets
• Market Restraints
  • High costs associated with tuberculosis diagnostics
  • Limited reimbursement options
• Market Opportunities
  • Rising number of government awareness programs
  • Advancement in the diagnostics procedures
• Market Challenges
  • Low coverage or absence of insurance in emerging markets

Porter's Five Forces: A Strategic Tool for Navigating the Tuberculosis Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tuberculosis Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tuberculosis Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tuberculosis Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tuberculosis Diagnostics Market

A detailed market share analysis in the Tuberculosis Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tuberculosis Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tuberculosis Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tuberculosis Diagnostics Market

A strategic analysis of the Tuberculosis Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tuberculosis Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Becton, Dickinson, and Company, bioMerieux SA, Bruker Corporation, Cepheid, Elisabeth Pharmacon, spol. s r.o., ELITech Group, F. Hoffmann-La Roche AG, Hologic Corporation, OSANG HEALTHCARE CO., LTD, PerkinElmer, Inc., Siemens AG, Thermo Fisher Scientific, Inc., and Turklab A.S..

Market Segmentation & Coverage

This research report categorizes the Tuberculosis Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test Type, market is studied across Drug-susceptibility Testing, Laboratory Methods, Mantoux Test, Nucleic Acid Testing, and Radiographic Methods.
• Based on Type, market is studied across Point-of-Care Technologies and Rapid Test.
• Based on End_User, market is studied across Diagnostics Research Laboratory and Hospital & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing burden of tuberculosis globally and need to diagnose at very early stage
    • 5.1.1.2. Increasing R&D investments and intensive diagnostics products in pipelines
    • 5.1.1.3. Supportive government initiatives and rising awareness in the emerging markets
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with tuberculosis diagnostics
    • 5.1.2.2. Limited reimbursement options
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising number of government awareness programs
    • 5.1.3.2. Advancement in the diagnostics procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Low coverage or absence of insurance in emerging markets
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Tuberculosis Diagnostics Market, by Test Type

• 6.1. Introduction
• 6.2. Drug-susceptibility Testing
• 6.3. Laboratory Methods
• 6.4. Mantoux Test
• 6.5. Nucleic Acid Testing
• 6.6. Radiographic Methods

7. Tuberculosis Diagnostics Market, by Type

• 7.1. Introduction
• 7.2. Point-of-Care Technologies
• 7.3. Rapid Test

8. Tuberculosis Diagnostics Market, by End_User

• 8.1. Introduction
• 8.2. Diagnostics Research Laboratory
• 8.3. Hospital & Clinics

9. Americas Tuberculosis Diagnostics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Tuberculosis Diagnostics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Tuberculosis Diagnostics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACON Laboratories, Inc.
• 3. Becton, Dickinson, and Company
• 4. bioMerieux SA
• 5. Bruker Corporation
• 6. Cepheid
• 7. Elisabeth Pharmacon, spol. s r.o.
• 8. ELITech Group
• 9. F. Hoffmann-La Roche AG
• 10. Hologic Corporation
• 11. OSANG HEALTHCARE CO., LTD
• 12. PerkinElmer, Inc.
• 13. Siemens AG
• 14. Thermo Fisher Scientific, Inc.
• 15. Turklab A.S.